389030 — Geninus Balance Sheet
0.000.00%
- KR₩60bn
- KR₩54bn
- KR₩6bn
Annual balance sheet for Geninus, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 21,712 | 44,849 | 30,748 | 19,827 | 10,244 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 404 | 312 | 2,962 | 3,701 | 3,515 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 23,374 | 49,527 | 36,553 | 25,863 | 17,984 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,773 | 7,567 | 8,338 | 13,138 | 14,003 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 30,397 | 58,062 | 45,830 | 40,526 | 33,089 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 38,141 | 5,563 | 2,306 | 4,895 | 9,804 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 41,621 | 6,156 | 2,560 | 6,041 | 10,852 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | -11,224 | 51,906 | 43,270 | 34,485 | 22,237 |
| Total Liabilities & Shareholders' Equity | 30,397 | 58,062 | 45,830 | 40,526 | 33,089 |
| Total Common Shares Outstanding |